- Home
- VECO vs JANX Comparison
VECO vs JANX Comparison
Compare VECO & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VECO
- JANX
- Stock Information
- Founded
- VECO 1945
- JANX 2017
- Country
- VECO United States
- JANX United States
- Employees
- VECO N/A
- JANX N/A
- Industry
- VECO Industrial Machinery/Components
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- VECO Technology
- JANX Health Care
- Exchange
- VECO Nasdaq
- JANX Nasdaq
- Market Cap
- VECO 1.4B
- JANX 1.4B
- IPO Year
- VECO 1994
- JANX 2021
- Fundamental
- Price
- VECO $25.48
- JANX $24.37
- Analyst Decision
- VECO Buy
- JANX Strong Buy
- Analyst Count
- VECO 6
- JANX 10
- Target Price
- VECO $27.33
- JANX $79.50
- AVG Volume (30 Days)
- VECO 868.2K
- JANX 645.3K
- Earning Date
- VECO 11-05-2025
- JANX 11-05-2025
- Dividend Yield
- VECO N/A
- JANX N/A
- EPS Growth
- VECO N/A
- JANX N/A
- EPS
- VECO 1.02
- JANX N/A
- Revenue
- VECO $700,334,000.00
- JANX $439,000.00
- Revenue This Year
- VECO N/A
- JANX N/A
- Revenue Next Year
- VECO $8.48
- JANX $591.60
- P/E Ratio
- VECO $25.32
- JANX N/A
- Revenue Growth
- VECO N/A
- JANX N/A
- 52 Week Low
- VECO $16.92
- JANX $21.97
- 52 Week High
- VECO $34.34
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- VECO 62.89
- JANX 51.47
- Support Level
- VECO $24.52
- JANX $23.62
- Resistance Level
- VECO $25.96
- JANX $25.35
- Average True Range (ATR)
- VECO 0.73
- JANX 1.15
- MACD
- VECO 0.02
- JANX 0.17
- Stochastic Oscillator
- VECO 81.89
- JANX 61.64
About VECO Veeco Instruments Inc.
Veeco Instruments Inc is a United States-based company engaged in designing, developing, and manufacturing thin-film process equipment, mainly used for producing electronic devices. The company focuses on semiconductor process equipment that addresses a range of challenging materials engineering problems for its customers. Its products include Laser Processing Systems, Lithography Systems, Ion Beam Systems, SiC CVD Systems, MOCVD Systems, Wet Processing Systems, MBE Technologies, Atomic Layer Deposition Systems, Physical Vapor Deposition Systems, Dicing and Lapping Systems, as well as Gas & Vapor Delivery Systems. The majority of the company's revenue is generated from sales to the Semiconductor Industry and within China.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.